{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-223025","form_type":"8-K","ticker":"AVIR","cik":"0001593899","company_name":"Atea Pharmaceuticals, Inc.","filed_at":"2021-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.726207+00:00","generated_at":"2026-06-30T02:57:31.403636+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Atea Pharmaceuticals subleases Boston HQ; monthly rent $65,790 starting Jan 2022","bullets":["Sublease 17,544 sq ft at 225 Franklin St, Boston; term Jan 1, 2022 to Dec 31, 2026.","Base rent $65,790/month (year 1), increasing 2% annually; plus operating expenses and taxes.","Sublandlord DataRobot provides $877,200 leasehold improvement allowance.","Existing lease at 125 Summer St expires July 2022; new space to be principal executive offices.","Sublease conditioned on Prime Landlord consent and continued existence of prime lease."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-223025","json":"https://secwatch.observer/filing/0001193125-21-223025.json","markdown":"https://secwatch.observer/filing/0001193125-21-223025.md","text":"https://secwatch.observer/filing/0001193125-21-223025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593899/000119312521223025/0001193125-21-223025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593899/000119312521223025/d69975d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T02:57:31.403636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}